Bile acid represses the peroxisome proliferator-activated receptor-γ coactivator-1 promoter activity in a small heterodimer partner-dependent manner

International Journal of Molecular Medicine

Volumn 19, Issue 5, 2007, Pages 751-756

  Yamagata, Kazuyuki ^a   Yoshimochi, Kenji ^a   Daitoku, Hiroaki ^a   Hirota, Keiko ^a   Fukamizu, Akiyoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Bile acid; Farnesoid X receptor; Peroxisome proliferators activated receptor (PPAR ) coactivator 1; Small heterodimer partner

Indexed keywords

BILE ACID; CELL RECEPTOR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA COACTIVATOR-1; PROTEIN KINASE B; SMALL HETERODIMER PARTNER PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; DOWN REGULATION; DRUG EFFECT; GENETICS; GLUCONEOGENESIS; HUMAN; METABOLISM; MOUSE; PROMOTER REGION;

ANIMALS; BILE ACIDS AND SALTS; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GLUCONEOGENESIS; HUMANS; MICE; MODELS, GENETIC; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 34248592080     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.5.751     Document Type: Article

References (32)

1. Claudel T, Staels B and Kuipers F: The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 25: 2020-2030, 2005.
2. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, et al: A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6: 517-526, 2000.
3. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J and Mangelsdorf DJ: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6: 507-515, 2000.
4. De Fabiani E, Mitro N, Gilardi F, Caruso D, Galli G and Crestani M: Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle. J Biol Chem 278: 39124-39132, 2003.
5. Yamagata K, Daitoku H, Shimamoto Y, Matsuzaki H, Hirota K, Ishida J and Fukamizu A: Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J Biol Chem 279: 23158-23165, 2004.
6. Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC, Kuipers F and Staels B: The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem 280: 29971-29979, 2005.
7. Duran-Sandoval D, Cariou B, Fruchart JC and Staels B: Potential regulatory role of the farnesoid X receptor in the metabolic syndrome. Biochimie 87: 93-98, 2005.
8. Ma K, Saha PK, Chan L and Moore DD: Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 116: 1102-1109, 2006.
9. Puigserver P, Wu Z, Park CW, Graves R, Wright M and Spiegelman BM: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-839, 1998. (Pubitemid 28155321)
10. Yoon JC, Puigserver P, Chen G, DonovanJ, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, et al: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413: 131-138, 2001. (Pubitemid 32867868)
11. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, et al: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413: 179-183, 2001. (Pubitemid 32867880)
12. Daitoku H, Yamagata K, Matsuzaki H, Hatta M and Fukamizu A: Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 52: 642-649, 2003. (Pubitemid 36323569)
13. Hatta M, Daitoku H, Matsuzaki H, Deyama Y, Yoshimura Y, Suzuki K, Matsumoto A and Fukamizu A: Regulation of alkaline phosphatase promoter activity by forkhead transcription factor FKHR. Int J Mol Med 9: 147-152, 2002.
14. Fukuoka M, Daitoku H, Hatta M, Matsuzaki H, Umemura S and Fukamizu A: Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. Int J Mol Med 12: 503-508, 2003.
15. Matsuzaki H, Daitoku H, Hatta M, Tanaka K and Fukamizu A: Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci USA 100: 11285-11290, 2003.
16. Shimamoto Y, Ishida J, Yamagata K, Saito T, Kato H, Matsuoka T, Hirota K, Daitoku H, Nangaku M, Fujii H, et al: Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene. J Biol Chem 279: 7770-7776, 2004.
17. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, et al: Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439: 484-489, 2006. (Pubitemid 43152840)
18. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ and Shan B: Identification of a nuclear receptor for bile acids. Science 284: 1362-1365, 1999.
19. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, et al: Bile acids: natural ligands for an orphan nuclear receptor. Science 284: 1365-1368, 1999.
20. Seol W, Choi HS and Moore DD: An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272: 1336-1339, 1996.
21. Bavner A, Sanyal S, Gustafsson JA and Treuter E: Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol Metab 16: 478-488, 2005. (Pubitemid 41660864)
22. Aoyama H, Daitoku H and Fukamizu A: Nutrient control of phosphorylation and translocation of Foxo1 in C57BL/6 and db/db mice. Int J Mol Med 18: 433-439, 2006.
23. Barthel A and Schmoll D: Novel concepts in insulin regulation of hepatic gluconeogenesis 10.1152/ajpendo.00253.2003. Am J Physiol Endocrinol Metab 285: E685-E692, 2003.
24. Barthel A, Schmoll D and Unterman TG: FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 16: 183-189, 2005. (Pubitemid 40603098)
25. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G and Gonzalez FJ: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102: 731-744, 2000.
26. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, Kuipers F and Staels B: Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53: 890-898, 2004. (Pubitemid 38436600)
27. Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk T, Grefhorst A, Bouchaert E, Fruchart JC, Gonzalez FJ, Kuipers F and Staels B: Transient impairment of the adaptive response to fasting in FXR-deficient mice. FEBS Lett 579: 4076-4080, 2005.
28. Wang L, Liu J, Saha P, Huang J, Chan L, Spiegelman B and Moore DD: The orphan nuclear receptor SHP regulates PGC- 1alpha expression and energy production in brown adipocytes. Cell Metab 2: 227-238, 2005.
29. Nozawa H: Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. Biochem Biophys Res Commun 336: 754-761, 2005.
30. Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, Willson TM and Edwards PA: Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci USA 103: 1006-1011, 2006.
31. Modica S and Moschetta A: Nuclear bile acid receptor FXR as pharmacological target: Are we there yet? FEBS Lett 580: 5492-5499, 2006.
32. Tobin JF and Freedman LP: Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy. Trends Endocrinol Metab 17: 284-290, 2006.